Advertisement
Research Article| Volume 19, ISSUE 4, P877-884, December 1999

French Gynecologic Cytology

DOI:https://doi.org/10.1016/S0272-2712(18)30096-9
French Gynecologic Cytology
Previous ArticleThe Effect of Benchmarking Clinical Practice with the Clinical Laboratory: An Institutional Case Study
Next ArticleCumulative Index 1999
      This paper is only available as a PDF. To read, Please Download here.
      Diagnostic schema may be developed on a national or global level, but may be varied depending on the local conditions. In this article, the differences between French and North American gynecologic cytology are discussed. This article emphasizes the training, diagnostic, technologic, and regulatory differences that exist in France. By studying such differences, local practices can learn potential benefits and why their currently used systems may be optimal.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribers receive full online access to your subscription and archive of back issues up to and including 2002.

      Content published before 2002 is available via pay-per-view purchase only.

      Subscribe:

      Subscribe to Clinics in Laboratory Medicine
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Register: Create an account
      Institutional Access: Sign in to ScienceDirect

      References

      1. AFAQAP: Recommandations de bonnes pratiques en anatomie et cytologie Pathologiques 1998

        • ANAES
        Recommandations pour la pratique clinique. Conduite à tenir devant un frottis anormal du col de l’utérus: le frottis du col. Conduite à tenir diagnostique devant un frottis anormal du col de l’utérus. Conduite à tenir thérapeutique devant un frottis anormal du col de l’utérus.
        cut down form: Rev Fr Gynecol Obstet. 1999; 94: 72-80
        • Cochand-Priollet B.
        • Members of AFAQAP—Commission 1
        Recommandations pour l’évaluation de qualité interne des frottis de dépistage du cancer du col utérin en France dans les structures d’anatomie et cytologie pathologiques.
        Arch Anat Cytol Pathol. 1998; 18: 221-226
        • Del Moral Aldz A.
        • Aupee M.
        • Batal-Steil S.
        • et al.
        A workshop report. Cancer screening in the European union.
        Eur J Cancer. 1994; 30A: 860-872
        • Diebold J.
        Rapport du groupe du travail sur le controle de qualité dans Fétude cytopathologique des frottis cervico-uterins en vue du dépistage des néoplasies cervicales. DGS, Fevrier1998
        • Dubois G.
        Cytologic screening for cervix cancer: Each year or each 3 years?.
        Eur J Obstet Gynecol. 1996; 65: 57-59
      7. European guidelines for quality assurance in cervix cancer screening.
        Eur J Cancer. 1993; 29A: 74

      8. Flenker H, Schneider V: Quality assurance in Germany. In Compendium on Quality Assurance, Proficiency Testing and Workload Limitations in Clinical Cytology. Tutorials of Cytology. Chicago, 1995, pp 22-24

        • Frable W.J.
        • Austin R.M.
        • Greening S.E.
        • et al.
        Medicolegal affairs. IAC Task Force Summary.
        Acta Cytol. 1998; 42: 76-119

      10. Hanselaar AFJM, Vooijs GP: Quality assurance in cytology in the Netherlands. In Compendium on Quality Assurance, Proficiency Testing and Workload Limitations in Clinical Cytology. Tutorials of Cytology. Chicago, 1995, pp 142-147

        • Marsan C.
        • Bergeron C.
        • Cartier I.
        • et al.
        Assurance de qualité en anatomocytopathologie [cancer du col]. Rapport du groupe de travail.
        Arch Anat Cytol Pathol. 1995; 43: 154-156
        • Marsan C.
        • Vacher-Lavenu M.C.
        Telepathology: A tool to aid in diagnosis and quality assurance in cervicovaginal cytology.
        Cytopathology. 1995; 6: 339-342
        • Marsan C.
        • Vacher-Lavenu M.C.
        • Cochand-Priollet B.
        A cytopathology consulting station.
        Pol J Pathol. 1998; 49: 41-42

      14. McGoogan E: Quality Assurance in cervical screening in the United Kingdom. In Compendium on Quality Assurance, Proficiency Testing and Workload Limitations in Clinical Cytology. Tutorials of Cytology. Chicago, 1995, pp 125-133

        • Monsonego J.
        Dépistage du cancer du col.
        Presse Med. 1997; 14: 668-669
        • Nagy G.K.
        False negative rate: A misnomer, misunderstood and misused.
        Acta Cytol. 1997; 41: 778-780

      17. Sancho-Garnier H, Ancelle-Parc RM, Martin E et al: Rapport final: Comité national du cancer. Avis N°9 sur le dépistage des cancers en France, Juin 1997

      18. Schaffer P: Dépistage du cancer du col de Futérus. In Sancho-Garnier H, Beraud C, Dore JF et al: Dépistage des Cancers. De la Médecine à la Santé Publique. 1996, pp 47-51

        • Solomon D.
        • Frable W.J.
        • Vooijs G.P.
        • et al.
        ASCUS and AGUS criteria. IAC Task Force summary.
        Acta Cytol. 1998; 42: 16-24

      20. Syrjanen KJ: Quality assurance in the cytopathology Laboratories of the Finnish Cancer Society. In: Tutorials of Cytology. Chicago, 1995, pp 134-141

        • Vacher-Lavenu M.C.
        Nouvelles techniques en cytologie du col utérin: Technique en monocouche et aide automatisée à la lecture.
        Rev Fr Gynecol Obstet. 1998; 93: 14-19
        • Vacher-Lavenu M.C.
        • Marsan C.
        Télécytoconsultation: Application du système TRANSPATH à la pathologie cer vico-vaginale.
        Arch Anat Cytol Pathol. 1995; 43: 262-265
        • Vacher-Lavenu M.C.
        • Molinie V.
        Note technique. La technique en monocouche: Evolution ou révolution en cytologie cervico-utérine.
        Ann Pathol. 1998; 18: 218-220
        • Vuong P.
        • Vacher-Lavenu M.C.
        • Marsan C.
        • Baviera E.
        Relecture assistée par ordinateur des frottis cervico-vaginaux colorés par la méthode de Papanicolaou: Evaluation du système Papnet à propos de 225 cas.
        Arch Anat Cytol Pathol. 1995; 43: 147-153
        • Wang S.C.
        • Ritchie M.J.
        • Atkinson B.F.
        Cervical cytologic smear false negative fraction: Reduction in a small community hospital.
        Acta Cytol. 1997; 41: 1690-1696
        • Weintraub J.
        The coming revolution in cervical cytology: A pathologist’s guide for the clinician.
        Références en gynécologie obstétrique. 1997; 5: 1-6
        • Ziol M.
        • Vacher-Lavenu M.C.
        Frottis cervico-vaginaux: Apports du dépistage automatisé.
        Ann Pathol. 1996; 5: 351-355
        • Ziol M.
        • Vacher-Lavenu M.C.
        • Heudes D.
        • et al.
        Expert consultation for pap smear cases: Reliability of selected field video-microscopy.
        Anal Quant Cytol Histol. 1999; 21: 35-41

      Article info

      Identification

      DOI: https://doi.org/10.1016/S0272-2712(18)30096-9

      Copyright

      © 1999 Elsevier Inc. Published by Elsevier Inc. All rights reserved.

      ScienceDirect

      Access this article on ScienceDirect
      We use cookies to help provide and enhance our service and tailor content. To update your cookie settings, please visit the for this site.
      Copyright © 2023 Elsevier Inc. except certain content provided by third parties. The content on this site is intended for healthcare professionals.


      RELX